News Industry News New study finds both components of blood pressure predict heart attack, stroke risk July 17, 2019
News Industry News Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial September 18, 2015
News Industry News US FDA Approves Expanded Indication For Brilinta To Include Long-term Use In Patients With a History of Heart Attack September 03, 2015